Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 84.153
Filtrar
1.
Recurso de Internet en Español | LIS - Localizador de Información en Salud | ID: lis-LISBR1.1-47015

RESUMEN

Site do Governo do Mexico publica, aviso epidemiologico: sobre o novo Coronavirus 2019-nCoV


Asunto(s)
Brotes de Enfermedades , Coronavirus
2.
Geneva; World Health Organization; 2020-02-06.
en Inglés | WHO IRIS | ID: who-330826
3.
Geneva; World Health Organization; 2020-02-05.
en Inglés | WHO IRIS | ID: who-330825
4.
Geneva; World Health Organization; 2020-02-04.
en Inglés | WHO IRIS | ID: who-330780
5.
Geneva; World Health Organization; 2020-02-03.
en Inglés | WHO IRIS | ID: who-330779
6.
Geneva; World Health Organization; 2020-02-02.
en Inglés | WHO IRIS | ID: who-330778
7.
Geneva; World Health Organization; 2020-02-01.
en Inglés | WHO IRIS | ID: who-330777
8.
MMWR Morb Mortal Wkly Rep ; 69(5): 125-129, 2020 Feb 07.
Artículo en Inglés | MEDLINE | ID: mdl-32027630

RESUMEN

Increased prevalence of illicitly manufactured fentanyl and fentanyl analogs has contributed substantially to overdose deaths in the United States (1-3). On October 26, 2015, CDC issued a Health Advisory regarding rapid increases in deaths involving fentanyl. This CDC Health Advisory has been updated twice to address increases in fentanyl and fentanyl analog overdoses and their co-occurrence with nonopioids (4). Deaths involving carfentanil, an analog reportedly 10,000 times more potent than morphine and 100 times more potent than fentanyl, were first reported in Florida, Michigan, and Ohio in 2016 and described in an August 2016 CDC Health Advisory (1,5). Carfentanil is used to rapidly immobilize large animals in veterinary medicine and has no U.S. approved therapeutic use in humans. Carfentanil's street price per dose is likely lower than that of heroin. During 2016 and 2017, an outbreak of carfentanil-involved fatal overdoses in Florida emerged, and the Medical Examiner jurisdiction serving Sarasota, Manatee, and DeSoto counties (the Sarasota area) was the outbreak epicenter. This report describes toxicology profiles, sociodemographic information, and geographic distributions of carfentanil-involved fatal overdoses (carfentanil deaths) in the Sarasota area compared with those in the rest of Florida (i.e., all Florida counties excluding Sarasota area) from January 2016 to December 2017. The Sarasota area accounted for 19.0% of 1,181 statewide carfentanil deaths that occurred during this time and experienced a peak in carfentanil deaths preceding the larger Florida outbreak. The report of a single carfentanil death from August to December 2017 (compared with 73 reported deaths during the same period in 2016) appeared to mark the end of the outbreak in the area. The threat of such rapid, intense fatal overdose outbreaks highlights the need for accelerated reporting, reliable data sharing systems, and novel proactive surveillance to support targeted prevention and response efforts by public health and safety organizations (6).


Asunto(s)
Brotes de Enfermedades , Sobredosis de Droga/mortalidad , Fentanilo/análogos & derivados , Adulto , Femenino , Fentanilo/envenenamiento , Florida/epidemiología , Humanos , Masculino , Persona de Mediana Edad
9.
MMWR Morb Mortal Wkly Rep ; 69(5): 140-146, 2020 Feb 07.
Artículo en Inglés | MEDLINE | ID: mdl-32027631

RESUMEN

On December 31, 2019, Chinese health officials reported a cluster of cases of acute respiratory illness in persons associated with the Hunan seafood and animal market in the city of Wuhan, Hubei Province, in central China. On January 7, 2020, Chinese health officials confirmed that a novel coronavirus (2019-nCoV) was associated with this initial cluster (1). As of February 4, 2020, a total of 20,471 confirmed cases, including 2,788 (13.6%) with severe illness,* and 425 deaths (2.1%) had been reported by the National Health Commission of China (2). Cases have also been reported in 26 locations outside of mainland China, including documentation of some person-to-person transmission and one death (2). As of February 4, 11 cases had been reported in the United States. On January 30, the World Health Organization (WHO) Director-General declared that the 2019-nCoV outbreak constitutes a Public Health Emergency of International Concern.† On January 31, the U.S. Department of Health and Human Services (HHS) Secretary declared a U.S. public health emergency to respond to 2019-nCoV.§ Also on January 31, the president of the United States signed a "Proclamation on Suspension of Entry as Immigrants and Nonimmigrants of Persons who Pose a Risk of Transmitting 2019 Novel Coronavirus," which limits entry into the United States of persons who traveled to mainland China to U.S. citizens and lawful permanent residents and their families (3). CDC, multiple other federal agencies, state and local health departments, and other partners are implementing aggressive measures to slow transmission of 2019-nCoV in the United States (4,5). These measures require the identification of cases and their contacts in the United States and the appropriate assessment and care of travelers arriving from mainland China to the United States. These measures are being implemented in anticipation of additional 2019-nCoV cases in the United States. Although these measures might not prevent the eventual establishment of ongoing, widespread transmission of the virus in the United States, they are being implemented to 1) slow the spread of illness; 2) provide time to better prepare health care systems and the general public to be ready if widespread transmission with substantial associated illness occurs; and 3) better characterize 2019-nCoV infection to guide public health recommendations and the development of medical countermeasures including diagnostics, therapeutics, and vaccines. Public health authorities are monitoring the situation closely. As more is learned about this novel virus and this outbreak, CDC will rapidly incorporate new knowledge into guidance for action by CDC and state and local health departments.


Asunto(s)
Betacoronavirus/aislamiento & purificación , Infecciones por Coronavirus/epidemiología , Infecciones por Coronavirus/virología , Brotes de Enfermedades/prevención & control , Adulto , Anciano , Infecciones por Coronavirus/prevención & control , Femenino , Humanos , Control de Infecciones , Laboratorios , Masculino , Persona de Mediana Edad , Guías de Práctica Clínica como Asunto , Práctica de Salud Pública , Estados Unidos/epidemiología
10.
Nature ; 578(7793): 15-16, 2020 02.
Artículo en Inglés | MEDLINE | ID: mdl-32020111
12.
Recurso de Internet en Inglés, Español, Francés | LIS - Localizador de Información en Salud | ID: lis-LISBR1.1-46962

RESUMEN

Site da Organización Mundial de la Salud, Sobre o novo Coronavirus


Asunto(s)
Coronavirus , Brotes de Enfermedades
13.
Recurso de Internet en Inglés, Español, Francés | LIS - Localizador de Información en Salud | ID: lis-LISBR1.1-46963

RESUMEN

Site da Organização Mundial da Saúde dos Estados Unidos. Informa a disponibiliza relatórios sobre o novo Coronavírus (2019-nCoV)


Asunto(s)
Coronavirus , Brotes de Enfermedades , Alerta en Emergencia
14.
Recurso de Internet en Español | LIS - Localizador de Información en Salud | ID: lis-LISBR1.1-46964

RESUMEN

Site da Organização Pan-americana da Argentina. disponibiliza relatórios sobre o novo Coronavírus (2019-nCoV) Preguntas frecuentes, presentaciones actualizadas OPS Argentina, Actualizaciones epidemiológicas OPS Sede, Informes de situación, Advertencia para viajeros, Notas de prensa, Ministerio de Salud de la Nación, Guías técnicas, Materiales sobre comunicación de riesgo


Asunto(s)
Coronavirus , Brotes de Enfermedades
15.
Geneva; World Health Organization; 2020-01-31.
en Inglés | WHO IRIS | ID: who-330776
16.
Geneva; World Health Organization; 2020-01-30.
en Inglés | WHO IRIS | ID: who-330775
18.
Geneva; World Health Organization; 2020-01-28.
en Inglés | WHO IRIS | ID: who-330773
19.
Geneva; World Health Organization; 2020-01-27.
en Inglés | WHO IRIS | ID: who-330771
20.
Geneva; World Health Organization; 2020-01-26.
en Inglés | WHO IRIS | ID: who-330770
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA